ArticleFrontiers in oncology2022

Olaparib Combined With Dacomitinib in Osimertinib-Resistant Brain and Leptomeningeal Metastases From Non-Small Cell Lung Cancer: A Case Report and Systematic Review.

Hui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.